Urachal carcinoma : surgical and chemotherapeutic optionsSIEFKER-RADTKE, Arlene.Expert review of anticancer therapy. 2006, Vol 6, Num 12, pp 1715-1721, issn 1473-7140, 7 p.Article

Urachal Adenocarcinoma: A Clinician's Guide for TreatmentSIEFKER-RADTKE, Arlene.Seminars in oncology. 2012, Vol 39, Num 5, pp 619-624, issn 0093-7754, 6 p.Article

Multimodality management of urachal carcinoma: The M. D. Anderson cancer center experienceSIEFKER-RADTKE, Arlene O; GEE, Jason; YU SHEN et al.The Journal of urology. 2003, Vol 169, Num 4, pp 1295-1298, issn 0022-5347, 4 p.Conference Paper

Neoadjuvant Chemotherapy in Small Cell Urothelial Cancer Improves Pathologic Downstaging and Long-term Outcomes: Results from a Retrospective Study at the MD Anderson Cancer CenterLYNCH, Siobhan P; YU SHEN; KAMAT, Ashish et al.European urology. 2013, Vol 64, Num 2, pp 307-313, issn 0302-2838, 7 p.Article

A Phase II Trial of Gemcitabine Plus Capecitabine for Metastatic Renal Cell Cancer Previously Treated With Immunotherapy and Targeted Agents. CommentaryTANNIR, Nizar M; THALL, Peter F; STADLER, Walter et al.The Journal of urology. 2008, Vol 180, Num 3, pp 867-872, issn 0022-5347, 6 p.Article

Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-α-2b : Results of a randomized phase II trial of low-dose versus intermediate-dose interferon-α-2b in patients with metastatic renal cell carcinomaTANNIR, Nizar M; COHEN, Lorenzo; XUEMEI WANG et al.Cancer. 2006, Vol 107, Num 9, pp 2254-2261, issn 0008-543X, 8 p.Article

Survival outcomes for men with mediastinal germ-cell tumors: The University of Texas M. D. Anderson Cancer Center experienceRODNEY, AlanJ; TANNIR, Nizar M; SIEFKER-RADTKE, Arlene O et al.Urologic oncology. 2012, Vol 30, Num 6, pp 879-885, issn 1078-1439, 7 p.Article

Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?SWEENEY, Paul; MILLIKAN, Randall; DONAT, Machele et al.The Journal of urology. 2003, Vol 169, Num 6, pp 2113-2117, issn 0022-5347, 5 p.Article

Neoadjuvant Chemotherapy Improves Survival of Patients With Upper Tract Urothelial CarcinomaPORTEN, Sima; SIEFKER-RADTKE, Arlene O; LIANCHUN XIAO et al.Cancer. 2014, Vol 120, Num 12, pp 1794-1799, issn 0008-543X, 6 p.Article

The role of radical cystectomy in patients with clinical T4b bladder cancerBLACK, Peter C; DINNEY, Colin P. N; BROWN, Gordon A et al.Urologic oncology. 2011, Vol 29, Num 2, pp 157-161, issn 1078-1439, 5 p.Article

A Phase 2 Clinical Trial of Sequential Neoadjuvant Chemotherapy With Ifosfamide, Doxorubicin, and Gemcitabine Followed by Cisplatin, Gemcitabine, and Ifosfamide in Locally Advanced Urothelial Cancer: Final ResultsSIEFKER-RADTKE, Arlene O; DINNEY, Colin P; YU SHEN et al.Cancer. 2013, Vol 119, Num 3, pp 540-547, issn 0008-543X, 8 p.Article

Perioperative Outcomes of Laparoscopic Radical Nephroureterectomy and Regional Lymphadenectomy in Patients With Upper Urinary Tract Urothelial Carcinoma After Neoadjuvant ChemotherapyZAK RAJPUT, M; KAMAT, Ashish M; CLAVELL-HERNANDEZ, Jonathan et al.Urology (Ridgewood, NJ). 2011, Vol 78, Num 1, pp 61-67, issn 0090-4295, 7 p.Article

Incidence of Downstaging and Complete Remission After Neoadjuvant Chemotherapy for High-Rish Upper Tract Transitional Cell CarcinomaMATIN, Surena F; MARGULIS, Vitaly; KAMAT, Ashish et al.Cancer. 2010, Vol 116, Num 13, pp 3127-3134, issn 0008-543X, 8 p.Article

Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: A contemporary review of the university of Texas M.D. anderson cancer center experienceKASSOUF, Wassim; SPIESS, Philippe E; SIEFKER-RADTKE, Arlene et al.Cancer. 2007, Vol 110, Num 4, pp 764-769, issn 0008-543X, 6 p.Article

Partial cystectomy for muscle invasive urothelial carcinoma of the bladder : A contemporary review of the M. D. Anderson cancer center experienceKASSOUF, Wassim; SWANSON, David; KAMAT, Ashish M et al.The Journal of urology. 2006, Vol 175, Num 6, pp 2058-2062, issn 0022-5347, 5 p.Article

Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-γ for metastatic renal cell carcinomaTANNIR, Nizar; JONASCH, Eric; TU, Shi-Ming et al.Cancer. 2006, Vol 107, Num 3, pp 497-505, issn 0008-543X, 9 p.Article

Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: A retrospective review of the M. D. Anderson cancer experienceSIEFKER-RADTKE, Arlene O; DINNEY, Colin P; ABRAHAMS, Neil A et al.The Journal of urology. 2004, Vol 172, Num 2, pp 481-484, issn 0022-5347, 4 p.Article

Micropapillary bladder cancer : A review of the University of Texas M. D. Anderson cancer center experience with 100 consecutive patientsKAMAT, Ashish M; DINNEY, Colin P. N; GEE, Jason R et al.Cancer. 2007, Vol 110, Num 1, pp 62-67, issn 0008-543X, 6 p.Article

Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experienceSIEFKER-RADTKE, Arlene O; WALSH, Garrett L; PISTERS, Louis L et al.The Journal of urology. 2004, Vol 171, Num 1, pp 145-148, issn 0022-5347, 4 p.Article

ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma—Neoadjuvant and Adjuvant Settings : ICUD-EAU International Consultation on Bladder Cancer 2012: Recommendations on Bladder Cancer-Process in a Cancer that Lacks the LimelightSTERNBERG, Cora N; BELLMUNT, Joaquim; VAUGHN, David J et al.European urology. 2013, Vol 63, Num 1, pp 58-66, issn 0302-2838, 9 p.Article

Sensitivity to Epidermal Growth Factor Receptor Inhibitor Requires E-Cadherin Expression in Urothelial Carcinoma CellsBLACK, Peter C; BROWN, Gordon A; BAR-ELI, Menashe et al.Clinical cancer research. 2008, Vol 14, Num 5, pp 1478-1486, issn 1078-0432, 9 p.Article

A Randomized Phase 2 Trial of Gemcitabine/Cisplatin With or Without Cetuximab in Patients With Advanced Urothelial CarcinomaHUSSAIN, Maha; DAIGNAULT, Stephanie; EISENBERGER, Mario A et al.Cancer. 2014, Vol 120, Num 17, pp 2684-2693, issn 0008-543X, 10 p.Article